杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 10 2021

Full Issue

Oklahoma Supreme Court Reverses $465M Opioid Ruling Against J&J

In a 5-1 ruling, the Oklahoma Supreme Court justices overturned a lower court's ruling that Johnson & Johnson had violated the state's public nuisance statute -- an argument on which thousands of opioid cases against drugmakers hinges.

The Oklahoma Supreme Court on Tuesday overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state鈥檚 public nuisance law in the first case of its kind in the U.S. to go to trial. The ruling was the second blow this month to a government case that used a similar approach to try to hold drugmakers responsible for the national epidemic of opioid abuse. Public nuisance claims are at the heart of some 3,000 lawsuits brought by state and local governments against drugmakers, distribution companies and pharmacies, but it鈥檚 not clear that the legal theory is in trouble with so many more cases queued up to test it. (Miller, 11/9)

鈥淚n reaching this decision, we do not minimize the severity of the harm that thousands of Oklahoma citizens have suffered because of opioids,鈥 the Oklahoma Supreme Court judges wrote in their ruling. 鈥淗owever grave the problem of opioid addiction is in Oklahoma, public nuisance law does not provide a remedy for this harm.鈥 The one dissenting judge, James E. Edmondson, said he disagreed with the ruling against J&J but thought the decision should be remanded to the lower court. Johnson & Johnson praised the ruling Tuesday. (Kornfield and Bernstein, 11/9)

The lawsuit featured the first trial in the nation that sought to hold the pharmaceutical industry accountable for widespread opioid addiction and overdoses. A state court judge found Johnson & Johnson created misleading and dangerous marketing campaigns for drugs and opioids that lacked context and exaggerated opioids鈥 safety and efficacy as pain treatments.聽The drugmaker was ordered in 2019 to pay hundreds of millions of dollars to help address the damage caused. The dollar amount鈥攊nitially $572 million but later reduced to $465 million鈥攔epresented an estimated year鈥檚 worth of treatment and programs. (Calfas, 11/9)

Meanwhile, the opioid crisis has not gone away 鈥

Fatal opioid overdoses nearly doubled in recent years among Massachusetts workers, with the construction, farming and fishing industries among the hardest hit sectors, according to an updated study from the state Department of Public Health released Monday. The new state report, which builds on a prior study covering 2011-2015, shows the rate of opioid-related overdose deaths among workers across all industries increased from 25 deaths per 100,000 workers from 2011-2015 to 46 in 2016-2017. (11/8)

It鈥檚 hard to be sure what Alissa Saunders thought she was taking the night she died of a drug overdose 鈥 a ground-up Percocet, maybe, or a pulverized bar of Xanax. One thing seems clear enough, though: She didn鈥檛 know it was fentanyl. Saunders, a 22-year-old certified nursing assistant who loved to camp, fish and hang out with her family, was found unresponsive last March in the New Lenox townhouse she shared with a roommate, a straw flecked with powdered residue on the nightstand beside her. (Keilman, 11/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 2
  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF